<DOC>
	<DOCNO>NCT03081741</DOCNO>
	<brief_summary>Conduct prospective study detect change ctDNA surgical lung cancer patient .</brief_summary>
	<brief_title>Circulating Tumor DNA Surgical Lung Cancer Patients</brief_title>
	<detailed_description>Studies show feasibility detect mutation status blood circulate tumor DNA ( ctDNA ) lung cancer patient . The investigator plan test blood ctDNA surveillance surgical lung cancer patient . And evaluate correlation ctDNA level tumor relapse metastasis .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<criteria>Aged 18 80 year Undergo radical surgery Histologically confirm diagnosis lung cancer Considered primary lung cancer clinical criterion Patients must give write informed consent Unable comply study procedure Malignant tumor history Patients receive treatment prior resection Unqualified blood sample</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>